The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling
Open accessAbstract
Immunoglobulin class switching is crucial for the generation of antibody diversity in humoral immunity and, when deregulated, also has severe pathological consequences. How the magnitude of immunoglobulin isotype switching is controlled is still poorly understood. Here we identify the kinase TBK1 as a pivotal negative regulator of class switching to the immunoglobulin A (IgA) isotype. B cell-specific ablation of TBK1 in mice resulted in uncontrolled production of IgA and the development of nephropathy-like disease signs. TBK1 negatively regulated IgA class switching by attenuating noncanonical signaling via the transcription factor NF-κB, an action that involved TBK1-mediated phosphorylation and subsequent degradation of the NF-κB-inducing kinase NIK. Our findings establish TBK1 as a pivotal negative regulator of the noncanonical NF-κB pathway and identify a unique mechanism that controls IgA production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent studies have demonstrated critical roles for TBK1 and/or IKK ε in regulation of activity of numerous immune cell types, including T cells 21 , B cells 22,23 , dendritic cells 24 , and macrophages 25,26 .”
From Targeting TBK1 to overcome resistance to cancer immunotherapy (2023) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., & Cerutti, A. (2002) · Nature Immunology · doi:10.1038/ni829 · Cited by 1,252
RetractedThe role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,954
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,475
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,680
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,635
Triggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G., Lin, R., & Hiscott, J. B. (2003) · Science · doi:10.1126/science.1081315 · Cited by 1,685
The immune geography of IgA induction and function
Macpherson, A. J., McCoy, K. D., Johansen, F.-E., & Brandtzaeg, P. (2007) · Mucosal Immunology · doi:10.1038/mi.2007.6 · Cited by 1,047
The regulation of IgA class switching
Cerutti, A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2322 · Cited by 777
The noncanonical NF‐κB pathway
Sun, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01088.x · Cited by 752
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Yu, H., Lin, L., Zhang, Z., Zhang, H., & Hu, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00312-6 · Cited by 2,329
Self-citationThe non-canonical NF-κB pathway in immunity and inflammation
Sun, S. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.52 · Cited by 1,959
Self-citationNF‐κB signaling in inflammation and cancer
Zhang, T., Ma, C., Zhang, Z., Zhang, H., & Hu, H. (2021) · MedComm · doi:10.1002/mco2.104 · Cited by 639
Self-citationNF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 601
Self-citationNF-κB in inflammation and renal diseases
Zhang, H., & Sun, S.-C. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0056-4 · Cited by 383
Self-citationRegulation of nuclear factor-κB in autoimmunity
Sun, S., Chang, J., & Jin, J. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.01.004 · Cited by 324
Self-citationHuang, B., Chen, Z., Geng, L., Wang, J., Liang, H., Cao, Y., Chen, H., Huang, W., Su, M., Wang, H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.027 · Cited by 309
Noncanonical NF-κB Signaling in Health and Disease
Cildir, G., Low, K. C., & Tergaonkar, V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.002 · Cited by 301
Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy
Hou, Y., Liang, H. L., Rao, E., Zheng, W., Huang, X., Deng, L., Zhang, Y., Yu, X., Xu, M. M., Mauceri, H. J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.008 · Cited by 278
Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems
Boyaka, P. N. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601775 · Cited by 258
TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue
Zhao, P., Wong, K. I., Sun, X., Reilly, S. M., Uhm, M., Liao, Z., Skorobogatko, Y., & Saltiel, A. R. (2018) · Cell · doi:10.1016/j.cell.2018.01.007 · Cited by 250
Helgason, E., Phung, Q. T., & Dueber, E. C. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.059 · Cited by 184
Targeting TBK1 to overcome resistance to cancer immunotherapy
Sun, Y., Revach, O.-Y., Anderson, S., Kessler, E. A., Wolfe, C. H., Jenney, A., Mills, C. E., Robitschek, E. J., Davis, T. G. R., Kim, S., et al. (2023) · Nature · doi:10.1038/s41586-023-05704-6 · Cited by 174
McDaniel, D. K., Eden, K. B., Ringel-Scaia, V. M., & Allen, I. C. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000858 · Cited by 167
Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
Pflug, K. M., & Sitcheran, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228470 · Cited by 163
The role of TBK1 in cancer pathogenesis and anticancer immunity
Runde, A. P., Mack, R. M., Breslin, P., & Zhang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02352-y · Cited by 159
Negative regulation of TBK1‐mediated antiviral immunity
Zhao, W. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.052 · Cited by 151
Willmann, K. L., Klaver, S., Doğu, F., Santos-Valente, E., Garncarz, W., Bilić, I., Mace, E. M., Salzer, E., Conde, C. D., Sic, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6360 · Cited by 157
Regulation of IRF3 activation in human antiviral signaling pathways
Hamrashdi, M. A., & Brady, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115026 · Cited by 137
TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis
Zhu, L., Li, Y., Xie, X., Zhou, X., Gu, M., Jie, Z., Ko, C.-J., Gao, T., Hernandez, B. E., Cheng, X., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0429-8 · Cited by 109
Self-citationNuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and Atherosclerosis
Yu, X., Zheng, X., & Tang, C. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.03.004 · Cited by 132
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
Brightbill, H. D., Suto, E., Blaquière, N., Ramamoorthi, N., Sujatha-Bhaskar, S., Gogol, E. B., Castanedo, G. M., Jackson, B. T., Kwon, Y. C., Haller, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02672-0 · Cited by 132
Song, N., Thaiss, F., & Guo, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00815 · Cited by 127
Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS–cGAMP–STING Pathway
Ritchie, C., Carozza, J. A., & Li, L. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-040320-101629 · Cited by 123
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
Yu, J., Zhou, X., Chang, M., Nakaya, M., Chang, J.-H., Xiao, Y., William Lindsey, J., Dorta-Estremera, S., Cao, W., Zal, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7074 · Cited by 118
Self-citationMolecular control of the NEMO family of ubiquitin-binding proteins
Clark, K., Nanda, S. K., & Cohen, P. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3644 · Cited by 123
Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer
Markopoulos, G. S., Roupakia, E., Tokamani, M., Alabasi, G., Sandaltzopoulos, R., Marcu, K. B., & Kolettas, E. (2018) · Biomedicines · doi:10.3390/biomedicines6020040 · Cited by 116
TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss
Hu, L., Xie, H., Liu, X., Potjewyd, F., James, L. I., Wilkerson, E., Herring, L. E., Xie, L., Chen, X., Cabrera, J. C., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0837 · Cited by 109
TBK1, a central kinase in innate immune sensing of nucleic acids and beyond
Zhou, R., Zhang, Q., & Xu, P. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa051 · Cited by 104
Expanding the View of IKK: New Substrates and New Biology
Antonia, R. J., Hagan, R. S., & Baldwin, A. S. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.12.003 · Cited by 106
Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor
Thomson, D. W., Poeckel, D., Zinn, N., Rau, C., Strohmer, K., Wagner, A. J., Graves, A. P., Perrin, J., Bantscheff, M., Duempelfeld, B., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00027 · Cited by 103
IκB kinase ɛ (IKKɛ): A therapeutic target in inflammation and cancer
Verhelst, K., Verstrepen, L., Carpentier, I., & Beyaert, R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.007 · Cited by 100
Xiao, Y., Zou, Q., Xie, X., Liu, T., Li, H. S., Jie, Z., Jin, J., Hu, H., Manyam, G., Zhang, L., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161524 · Cited by 87
Self-citationHeterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice
Brenner, D., Sieverding, K., Bruno, C., Lüningschrör, P., Buck, E., Mungwa, S., Fischer, L., Brockmann, S. J., Ulmer, J., Bliederhäuser, C., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180729 · Cited by 83
CD40-Mediated Activation of the NF-κB2 Pathway
Hostager, B. S., & Bishop, G. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00376 · Cited by 90
Roles for the IKK-Related Kinases TBK1 and IKKε in Cancer
Durand, J. K., Zhang, Q. H., & Baldwin, A. S. (2018) · Cells · doi:10.3390/cells7090139 · Cited by 73
Pedros, C., Zhang, Y., Hu, J. K., Choi, Y. S., Canonigo-Balancio, A. J., Yates, J. R., Altman, A., Crotty, S., & Kong, K. (2016) · Nature Immunology · doi:10.1038/ni.3463 · Cited by 76
Peli1 negatively regulates noncanonical NF-κB signaling to restrain systemic lupus erythematosus
Liu, J., Huang, X., Hao, S., Wang, Y., Liu, M., Xu, J., Zhang, X., Yu, T., Gan, S., Dai, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03530-3 · Cited by 69
Self-citationTANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity
Louis, C., Burns, C. J., & Wicks, I. P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00434 · Cited by 64
Brightbill, H. D., Jackman, J. K., Suto, E., Kennedy, H., Jones, C., Chalasani, S., Lin, Z., Tam, L., Roose-Girma, M., Balázs, M., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401514 · Cited by 65
Noncanonical NF-κB Signaling Is Limited by Classical NF-κB Activity
Gray, C. M., Remouchamps, C., McCorkell, K. A., Solt, L. A., Dejardin, E., Orange, J. S., & May, M. J. (2014) · Science Signaling · doi:10.1126/scisignal.2004557 · Cited by 62
Chen, M., Zhao, Z., Meng, Q., Liang, P., Su, Z., Wu, Y., Huang, J., & Cui, J. (2019) · Advanced Science · doi:10.1002/advs.201901261 · Cited by 55
Xu, W., Mo, J., Ocak, U., Travis, Z. D., Enkhjargal, B., Zhang, T., Wu, P., Peng, J., Li, T., Zuo, Y., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00772-x · Cited by 48
Zhong, Z., Zhang, H., Nan, K., Zhong, J., Wu, Q., Lu, L., Yue, Y., Zhang, Z., Guo, M., Wang, Z., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0323 · Cited by 50
Duan, W., Guo, M., Yi, L., Zhang, J., Bi, Y., Liu, Y., Li, Y., Li, Z., Ma, Y., Zhang, G., et al. (2019) · Aging · doi:10.18632/aging.101936 · Cited by 51
Transcriptome analysis of response mechanism to ammonia stress in Asian clam (Corbicula fluminea)
Zhang, T., Yan, Z., Zheng, X., Fan, J., Wang, S., Wei, Y., Yang, L., Wang, P., & Guo, S. (2019) · Aquatic Toxicology · doi:10.1016/j.aquatox.2019.105235 · Cited by 45
Huang, T., Gao, Z., Zhang, Y., Fan, K.-Q., Wang, F., Li, Y., Zhong, J.-Y., Fan, H., Cao, Q., Zhou, J., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180210 · Cited by 41
Self-citationA TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling
Parvatiyar, K., Pindado, J., Dev, A., Aliyari, S. R., Zaver, S. A., Gerami, H., Chapon, M., Ghaffari, A. A., Dhingra, A., & Cheng, G. (2018) · Nature Communications · doi:10.1038/s41467-018-05168-7 · Cited by 43
NIK as a Druggable Mediator of Tissue Injury
Rivas, L. V., Vaquero, J. J., Sucunza, D., Gutiérrez, S., Sanz, A. B., Fresno, M., Ortíz, A., & Sánchez-Niño, M. D. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.02.005 · Cited by 42
A review on the role of TANK-binding kinase 1 signaling in cancer
Alam, M., Hasan, G. M., & Hassan, M. I. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.022 · Cited by 43
Signaling mechanisms regulating B-lymphocyte activation and tolerance
Hobeika, E., Nielsen, P. J., & Medgyesi, D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1252-8 · Cited by 42
METTL23 mutation alters histone H3R17 methylation in normal-tension glaucoma
Pan, Y., Suga, A., Kimura, I., Kimura, C., Minegishi, Y., Nakayama, M., Yoshitake, K., Iejima, D., Minematsu, N., Yamamoto, M., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153589 · Cited by 39
NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis
Wang, B., & Shen, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.895636 · Cited by 42
Lee, S., Shin, J., Kim, J.-S., Shin, J., Lee, S. K., & Park, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.743700 · Cited by 38
James, K. R., Soon, M. S. F., Sebina, I., Fernandez‐Ruiz, D., Davey, G. M., Liligeto, U. N., Nair, A. S., Fogg, L. G., Edwards, C. L., Best, S. E., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700782 · Cited by 32
Myeloid cell TBK1 restricts inflammatory responses
Gao, T., Liu, T., Ko, C., Zhang, L., Joo, D., Xie, X., Zhu, L., Li, Y., Cheng, X., & Sun, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107742119 · Cited by 35
Self-citationA Complex Relationship between TRAF3 and Non-Canonical NF-κB2 Activation in B Lymphocytes
Lin, W., Hildebrand, J. M., & Bishop, G. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00477 · Cited by 34
NF-kappaB-inducing kinase in cancer
Maubach, G., Feige, M. H., Lim, M. C. C., & Naumann, M. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.10.002 · Cited by 33
Duran, C. L., Lee, D. W., Jung, J.-U., Ravi, S., Pogue, C. B., Toussaint, L. G., Bayless, K. J., & Sitcheran, R. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.39 · Cited by 32
Intestinal Epithelial TBK1 Prevents Differentiation of T-helper 17 Cells and Tumorigenesis in Mice
Yang, J., Jie, Z., Mathews, A., Zhou, X., Li, Y., Gu, M., Xie, X., Ko, C., Cheng, X., Qi, Y., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.07.047 · Cited by 32
Self-citationNeutrophils negatively regulate induction of mucosal IgA responses after sublingual immunization
Jee, J., Bonnegarde-Bernard, A., Duverger, A. E., Iwakura, Y., Cormet‐Boyaka, E., Martin, T. L., Steiner, H. E., Bachman, R. C., & Boyaka, P. N. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.105 · Cited by 30
Noncanonical NF-κB Signaling Pathway in Liver Diseases
Chen, Q., Lu, X., & Zhang, X. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00063 · Cited by 30
Gitlin, A. D., Maltzman, A., Kanno, Y., Heger, K., Reja, R., Schubert, A. F., Wierciszewski, L. J., Pantua, H., Kapadia, S. B., Harris, S. F., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.004 · Cited by 28
Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43 transgenic mice
Sieverding, K., Ulmer, J., Bruno, C., Satoh, T., Tsao, W., Freischmidt, A., Akira, S., Wong, P. C., Ludolph, A. C., Danzer, K. M., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113496 · Cited by 30
TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex
Shi, J., & Sun, S. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.024 · Cited by 31
Self-citationTrares, K., Ackermann, J., & Koch, I. (2021) · Biosystems · doi:10.1016/j.biosystems.2021.104564 · Cited by 29
Regulation of pyroptosis by NF-κB signaling
Yang, L., Zhang, Y., Chai, Z., Zhou, Y., Li, Z., & Wei, Y. (2025) · Frontiers in Cell Death · doi:10.3389/fceld.2024.1503799 · Cited by 28
Signaling control of antibody isotype switching
Chen, Z., & Wang, J. H. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.01.001 · Cited by 28
The chemical biology of IL-12 production via the non-canonical NFkB pathway
Koch, P. D., Pittet, M. J., & Weissleder, R. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00022a · Cited by 25
Rehman, R., Tar, L., Olamide, A. J., Li, Z., Kassubek, J., Böckers, T. M., Weishaupt, J. H., Ludolph, A. C., Wiesner, D., & Roselli, F. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.684171 · Cited by 24
Prospects for gene replacement therapies in amyotrophic lateral sclerosis
Giovannelli, I., Higginbottom, A., Kirby, J., Azzouz, M., & Shaw, P. J. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00751-5 · Cited by 23
Myeloid TBK1 Signaling Contributes to the Immune Response to Influenza
Hagan, R. S., Torres-Castillo, J. L., & Doerschuk, C. M. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0122oc · Cited by 23
Lee, M. S. J., Inoue, T., Ise, W., Matsuo-Dapaah, J., Wing, J. B., Temizoz, B., Kobiyama, K., Hayashi, T., Patil, A., Sakaguchi, S., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20211336 · Cited by 21
Protein kinase networks that limit TLR signalling
Clark, K. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130124 · Cited by 21
All roads lead to IgA : Mapping the many pathways of IgA induction in the gut
Siniscalco, E. R., Williams, A., & Eisenbarth, S. C. (2024) · Immunological Reviews · doi:10.1111/imr.13369 · Cited by 20
Krug, A., Tari, G., Saidane, A., Gaulard, P., Ricci, J., Lemonnier, F., & Verhoeyen, E. (2022) · Cancers · doi:10.3390/cancers14102392 · Cited by 22
Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats
Ta, M. H. T., Schwensen, K. G., Liuwantara, D., Huso, D. L., Watnick, T. J., & Rangan, G. K. (2016) · World Journal of Nephrology · doi:10.5527/wjn.v5.i4.339 · Cited by 21
TBK1 as a regulator of autoimmunity and antitumor immunity
Shi, J., Xie, X., & Sun, S. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.165 · Cited by 19
Self-citationAlam, M., Ansari, M. M., Noor, S., Mohammad, T., Hasan, G. M., Kazim, S. N., & Hassan, M. I. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.157 · Cited by 21
Kong, S., Dong, H., Song, J. J., Thiruppathi, M., Prabhakar, B. S., Qiu, Q., Lin, Z., Chini, E. N., Zhang, B., & Fang, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500713 · Cited by 19
LUBAC enables tumor-promoting LTβ receptor signaling by activating canonical NF-κB
Chen, Y., Rieser, E., Bhamra, A., Šurinová, S., Kreuzaler, P. A., Ho, M.-H., Tsai, W., Peltzer, N., de Miguel, D., & Walczak, H. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01355-w · Cited by 18
The Therapeutic Potential of Targeting NIK in B Cell Malignancies
Haselager, M. V., & Eldering, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.930986 · Cited by 21
IKKε and TBK1 prevent RIPK1 dependent and independent inflammation
Eren, R. O., Kaya, G. G., Schwarzer, R., & Pasparakis, M. (2024) · Nature Communications · doi:10.1038/s41467-023-44372-y · Cited by 18
Xie, J., Cheng, J., Ko, H., & Tang, Y. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00046-w · Cited by 17
Poxviral Targeting of Interferon Regulatory Factor Activation
Lawler, C., & Brady, G. (2020) · Viruses · doi:10.3390/v12101191 · Cited by 18
Recent progress in small molecule TBK1 inhibitors: a patent review (2015– 2020)
Thomson, D. W., & Bergamini, G. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1904893 · Cited by 16
Zhang, W., Jia, M., Lian, J., Lu, S., Zhou, J., Fan, Z., Zhu, Z., He, Y., Huang, C., Zhu, M., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14170 · Cited by 16
Lin, L., Yu, H., Li, L., Yang, W., Chen, X., Gong, Y., Lei, Q., Li, Z., Zhou, Z., Dai, L., et al. (2023) · Science Signaling · doi:10.1126/scisignal.abn5410 · Cited by 16
Self-citationKong, S., Thiruppathi, M., Qiu, Q., Lin, Z., Dong, H., Chini, E. N., Prabhakar, B. S., & Fang, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401798 · Cited by 16
Zhang, Z., Huang, L., Wu, Q., Yang, E., Zhang, G., Sun, H., & Wang, F. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1816-2 · Cited by 16
TANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases
Lü, H., Chen, X., Huang, M., Jiang, Y., & Liu, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051941 · Cited by 15
IKKe in osteoclast inhibits the progression of methylprednisolone-induced osteonecrosis
Liu, Y., Shan, H., Zong, Y., Lin, Y., Xia, W., Wang, N., Zhou, L., Gao, Y., Ma, X., Jiang, C., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57962 · Cited by 15
Sun, X., Hosomi, K., Shimoyama, A., Yoshii, K., Lan, H., Wang, Y., Yamaura, H., Nagatake, T., Ishii, K. J., Akira, S., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109852 · Cited by 15
CD11b regulates antibody class switching via induction of AID
Park, S., Sim, H., Kim, H., Jeong, D., Wu, G. J., Cho, S. Y., Lee, Y. S., Kwon, H., & Lee, K. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.04.005 · Cited by 15
Bruno, C., Sieverding, K., Freischmidt, A., Satoh, T., Walther, P., Mayer, B., Ludolph, A. C., Akira, S., Yilmazer‐Hanke, D., Danzer, K. M., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa133 · Cited by 14
Gray, C. M., McCorkell, K. A., Chunduru, S. K., McKinlay, M. A., & May, M. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.122 · Cited by 13
The path less traveled: the non-canonical NF-κB pathway in systemic lupus erythematosus
Montano, H., Allen, I. C., & Reilly, C. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1588486 · Cited by 12
miR-200bc/429 cluster alleviates inflammation in IgA nephropathy by targeting TWEAK/Fn14
Guo, Y., & Liao, Y. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.09.002 · Cited by 12
Dynamic modulation of the non-canonical NF-κB signaling pathway for HIV shock and kill
Chandrasekar, A. P., Maynes, M. A., & Badley, A. D. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1354502 · Cited by 11
Poly IC pretreatment suppresses B cell-mediated lupus-like autoimmunity through induction of Peli1
Wang, Y., Yuan, J., Dai, D., Liu, J., Xu, J., Miao, X., Wang, H., Mao, C., & Xiao, Y. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy082 · Cited by 11
Self-citation
Metadata
- Authors
- Jin, J., Xiao, Y., Chang, J.-H., Yu, J., Hu, H., Starr, R., Brittain, G. C., Chang, M., Cheng, X., & Sun, S.-C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- St Vincents Institute of Medical Research (AU)
- Corresponding author
- Sun, Shao-Cong
- Venue
- Nature Immunology
- Published
- 2012-09-30
- Volume
- 13
- Issue
- 11
- Pages
- 1101-1109
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3477307
- OpenAlex
- W2461505078
- Cited by
- 136
- References
- 53
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 8 · 2023: 10 · 2022: 15 · 2021: 12 · 2020: 12 · 2019: 12 · 2018: 15 · 2017: 7 · 2016: 6 · 2015: 10 · 2014: 5 · 2013: 8 · 2012: 2
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-07-03)
- Open access
- green
- europepmc.org
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Amgen
- National Cancer Institute (T32CA009598, P30CA016672)
- National Institute of General Medical Sciences (R01GM084459, GM084459)
- National Institute of Allergy and Infectious Diseases (AI064639, R01AI057555, R37AI064639, R01AI064639, AI057555)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TBK1, IgA class switching, non-canonical NF-κB signaling, NIK, B cells, humoral immunity, antibody isotype switching
- MeSH terms
- NF-kappaB-Inducing Kinase, Animals, B-Lymphocytes, Gene Expression Regulation, Glomerulonephritis, IGA, Immunoglobulin A, Phosphorylation, Signal Transduction, NF-kappa B, Protein Serine-Threonine Kinases, Gene Deletion, Immunoglobulin Class Switching, Mice, Knockout, Mice, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review